1,439 results match your criteria Cardiovascular Revascularization Medicine [Journal]


Safety and feasibility of coronary lithotripsy supported by guide extension catheter for the treatment of calcified lesion in angulated vessel.

Cardiovasc Revasc Med 2019 Feb 14. Epub 2019 Feb 14.

Interventional Cardiology, Hospital Clínico San Carlos, Madrid, Spain.

We report a case of successful coronary intervention with coronary lithotripsy facilitated by guide extension catheter for the treatment of severely calcified and bent vessel. Even though lithotripsy balloon currently available is relatively bulky, the contemporary rapid exchange guide extension catheter accommodated it with ease and helped smooth delivery of it. The present case showed the usefulness of this device combination for patients with complex coronary anatomies. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2019.02.014DOI Listing
February 2019

Meta-analysis of efficacy and safety of proton pump inhibitors with dual antiplatelet therapy for coronary artery disease.

Cardiovasc Revasc Med 2019 Feb 10. Epub 2019 Feb 10.

Guthrie Health System/Robert Packer Hospital, Sayre, PA, USA.

Background: There is inconsistency in the literature regarding the clinical effects of proton pump inhibitors (PPI) when added to dual antiplatelet therapy (DAPT) in subjects with coronary artery disease (CAD). We performed meta-analysis stratified by study design to explore these differences.

Methods And Results: 39 studies [4 randomized controlled trials (RCTs) and 35 observational studies) were selected using MEDLINE, EMBASE and CENTRAL (Inception-January 2018). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2019.02.002DOI Listing
February 2019

Development and validation of a novel risk score for primary percutaneous coronary intervention for ST elevation myocardial infarction.

Cardiovasc Revasc Med 2018 Dec 27. Epub 2018 Dec 27.

Department of Cardiovascular Science, University of Sheffield, UK; Department of Cardiology, Northern General Hospital, Sheffield, UK.

Background: Primary percutaneous coronary intervention (PPCI) is the default treatment for patients with ST elevation myocardial infarction (STEMI) and carries a higher risk of adverse outcomes when compared with elective and urgent PCI. Conventional PCI risk scores tend to be complex and may underestimate the risk associated with PPCI due to under-representation of patients with STEMI in their datasets. This study aimed to develop a simple, practical and contemporary risk model to provide risk stratification in PPCI. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2018.12.020DOI Listing
December 2018

Reproducibility of semi-automated three-dimensional volumetric analysis using cardiac computed tomography in patients with left ventricular assist device.

Cardiovasc Revasc Med 2019 Jan 23. Epub 2019 Jan 23.

MedStar Washington Hospital Center, Washington, D.C., United States of America; MedStar Cardiovascular Research Network, Washington, D.C., United States of America. Electronic address:

Background: Multi-detector gated cardiac computed tomography (CCT) allows three-dimensional (3D) quantification of cardiac chambers and is clinically indicated to assess left ventricular assist device (LVAD) malfunction and complications. Automated volumetric analysis is, however, disrupted by inflow cannula artifact in patients with LVAD. With this study, we evaluated intra-observer variability in semi-automated 3D cardiac volumetric analysis using CCT in patients with LVADs. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2019.01.024DOI Listing
January 2019

Outcomes of coronary artery revascularization procedures in patients with antiphospholipid syndrome.

Cardiovasc Revasc Med 2019 Jan 25. Epub 2019 Jan 25.

Montefiore Medical Center Albert Einstein College of Medicine, Bronx, NY 10467, United States of America.

Background: Published data on the outcome of coronary artery revascularization in patients with antiphospholipid syndrome (APS) are limited. Because APS is associated with a high rate of arterial thrombosis, there is concern that coronary revascularization in this group may be complicated by increased need for repeat revascularization. We aimed to determine the incidence and timing of repeat revascularization performed in patients with APS undergoing percutaneous coronary interventions (PCI) or coronary artery bypass grafting (CABG). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2019.01.027DOI Listing
January 2019
1 Read

A Bayesian network meta-analysis of preventive strategies for contrast-induced nephropathy after cardiac catheterization.

Cardiovasc Revasc Med 2019 Jan 12;20(1):29-37. Epub 2018 Jun 12.

Guthrie Health System/Robert Packer Hospital, Sayre, PA, USA; Rutgers New Jersey Medical School, Newark, NJ, USA; The Geisinger Commonwealth Medical College, Scranton, PA, USA.

Background: The optimal preventive strategy for contrast induced acute kidney injury (CIAKI) in patients undergoing cardiac catheterization remains uncertain.

Objective: We conducted Bayesian network meta-analysis (NMA) to compare different preventive strategies for CIAKI in these cohorts.

Methods: Forty-nine randomized controlled trials were extracted using MEDLINE, EMBASE and CENTRAL data bases (inception-1st December 2017). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2018.06.005DOI Listing
January 2019
2 Reads

Comparison in prevalence, predictors, and clinical outcome of VSR versus FWR after acute myocardial infarction: The prospective, multicenter registry MOODY trial-heart rupture analysis.

Cardiovasc Revasc Med 2019 Jan 23. Epub 2019 Jan 23.

Division of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. Electronic address:

Background: Differences in the predictors between ventricular septal rupture (VSR) and free wall rupture (FWR) have not been fully studied. Data on the prevalence and clinical outcome of heart rupture are limited.

Hypothesis: This study aimed to investigate heart rupture incidence and clinical results in patients with acute myocardial infarction (AMI). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2019.01.023DOI Listing
January 2019
1 Read

Left bundle branch block after transcatheter aortic valve implantation with Edwards Sapien 3 valve: Influence of the valve depth implantation.

Cardiovasc Revasc Med 2019 Jan 9. Epub 2019 Jan 9.

Clinical Cardiology, Hospital Universitario HM Montepríncipe, Spain.

Objectives: The aim of this study is to determine the relation between the valve depth implantation and the new-onset left bundle branch block (LBBB) in patients treated with transcatheter aortic valve implantation (TAVI) using Edwards Sapien 3 (S3) prosthesis.

Background: LBBB is the most common conduction disturbance after TAVI. The S3 has been associated with a higher incidence of LBBB. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2019.01.006DOI Listing
January 2019
1 Read

Saphenous vein graft sacrifice following native vessel PCI is safe and associated with favourable longer-term outcomes.

Cardiovasc Revasc Med 2019 Jan 24. Epub 2019 Jan 24.

Belfast Health and Social Care Trust, Belfast, United Kingdom.

Background: Competitive flow from saphenous vein grafts (SVG) that remain patent following percutaneous coronary intervention (PCI) of the native vessel may compromise durability of the reconstructed vessel. SVG sacrifice has been advocated, but the safety and longer-term outcomes of this are unknown.

Methods: We retrospectively reviewed all post-bypass patients who following successful PCI of the native vessel underwent attempted saphenous vein graft (SVG) closure between January 2014 and July 2018 in two institutions. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2019.01.025DOI Listing
January 2019
1 Read

Initial intravascular ultrasound without a routine early baseline study in the evaluation of cardiac transplant vasculopathy has prognostic valve.

Cardiovasc Revasc Med 2019 Jan 25. Epub 2019 Jan 25.

Division of Cardiology, The University of Arizona Sarver Heart Center, Tucson, AZ, United States of America; CareMore HealthCare, Tucson, AZ, United States of America. Electronic address:

Background: Abnormal minimal intimal thickening (MIT) on intravascular ultrasound (IVUS) defined as difference of ≥0.5 mm between baseline and one-year post-transplantation has been shown to have prognostic value. The goal of this retrospective cohort study was to evaluate whether abnormal MIT found on routine IVUS studies in cardiac transplant patients after 6 months without an early baseline study (modified MIT or MMIT), has any prognostic value. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2019.01.028DOI Listing
January 2019
1 Read

Translating Experimental Evidence Into Clinical Decision Making.

Cardiovasc Revasc Med 2019 Jan;20(1):9-10

Cardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2018.12.004DOI Listing
January 2019

Shedding Light Into Late Saphenous Vein Graft Failure.

Cardiovasc Revasc Med 2019 Jan;20(1):6-8

Deutsches Herzzentrum München, Munich, Germany; Deutsches Zentrum für Herz- und Kreislaufforschung e.V., Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2018.12.008DOI Listing
January 2019

TAVR for Bicuspid Aortic Valves: Past Is Prologue or Tempest in a Teapot?

Cardiovasc Revasc Med 2019 Jan;20(1)

Department of Cardiovascular Surgery, Houston Methodist Hospital, United States of America. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2018.11.025DOI Listing
January 2019

Bioresorbable Scaffolds and Bifurcations.

Cardiovasc Revasc Med 2019 Jan;20(1)

Department of Cardiology, Radboudumc, Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2018.12.014DOI Listing
January 2019

Continued Momentum in Catheter-Based Renal Denervation: The More the Merrier-Better Denervation Wins Again.

Authors:
Tim A Fischell

Cardiovasc Revasc Med 2019 Jan 19;20(1):2-3. Epub 2018 Dec 19.

Borgess Heart Institute, 1521 Gull Road, Kalamazoo, MI, 49008; Western Michigan University, Kalamazoo, MI; Ablative Solutions, 6203 San Ignacio Ave., Ste. 110, San Jose, CA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2018.12.009DOI Listing
January 2019

CRM: The Next Milestone.

Authors:
Ron Waksman

Cardiovasc Revasc Med 2019 Jan;20(1)

Georgetown University; MedStar Heart and Vascular Institute, MedStar Washington Hospital Center, 110 Irving St., NW, Suite 4B-1, Washington, DC 20010. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2018.12.003DOI Listing
January 2019

How should we treat heavily calcified coronary artery disease in contemporary practice? From atherectomy to intravascular lithotripsy.

Cardiovasc Revasc Med 2019 Jan 10. Epub 2019 Jan 10.

Oxford Heart Centre, John Radcliffe Hospital, Oxford, United Kingdom.

Heavily calcified and densely fibrotic coronary lesions continue to represent a challenge for percutaneous coronary intervention (PCI), as they are difficult to dilate, and it is difficult to deliver and implant drug-eluting stents (DES) properly. Poor stent deployment is associated with high rates of periprocedural complications and suboptimal long-term clinical outcomes. Thanks to the introduction of several adjunctive PCI tools, like cutting and scoring balloons, atherectomy devices, and to the novel intravascular lithotripsy technology, the treatment of such lesions has become increasingly feasible, predictable and safe. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2019.01.010DOI Listing
January 2019

Impact of predilation before transcatheter aortic valve implantation with new-generation devices.

Cardiovasc Revasc Med 2019 Jan 23. Epub 2019 Jan 23.

Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy; IRCCS NEUROMED, Pozzilli, Italy. Electronic address:

Background: Significant aortic stenosis can be effectively treated with transcatheter aortic valve implantation (TAVI) in patients at high or intermediate surgical risk. Predilation is often performed to facilitate TAVI implantation, but its risk-benefit balance with new-generation devices is detabed. We aimed to appraise whether predilation is still needed with new-generation devices for TAVI. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2019.01.017DOI Listing
January 2019
1 Read

Sex-specific predictors of mortality following balloon aortic valvuloplasty.

Cardiovasc Revasc Med 2019 Jan 19. Epub 2019 Jan 19.

Department of Medicine, Stony Brook University Medical Center, Stony Brook, NY, United States of America. Electronic address:

Background: A differential impact of sex has been observed in balloon aortic valvuloplasty (BAV) outcomes from small observational studies. Accordingly, we sought to compare mortality in men and women undergoing BAV and identify sex-specific predictors of mortality.

Methods: The Nationwide Inpatient Sample was screened for hospitalizations involving adults who underwent BAV between 2006 and 2014. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2019.01.001DOI Listing
January 2019
1 Read

Feasibility of a porcine arteriovenous shunt model for assessment of acute thrombogenicity in bifurcation stenting technique by optical coherence tomography.

Cardiovasc Revasc Med 2019 Jan 4. Epub 2019 Jan 4.

Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, USA.

Background: Double kissing (DK) crush stenting has been reported as a superior bifurcation stenting strategy compared to culotte stenting. However, the mechanism associated with the reduction of clinical events by DK crush stenting remains unclear. We therefore investigated the thrombogenicity of DK crush stenting and culotte stenting with both bare-metal stents (BMS) and drug-eluting stents (DES) and the feasibility of a novel porcine arteriovenous shunt model. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2018.12.025DOI Listing
January 2019

Role of intracoronary fibrinolytic therapy in contemporary PCI practice.

Cardiovasc Revasc Med 2018 Dec 27. Epub 2018 Dec 27.

Department of Internal Medicine, Rashid Hospital, Dubai, United Arab Emirates.

Plaque rupture or plaque erosion leads to intracoronary thrombus formation resulting in coronary artery occlusion and ST-segment elevation myocardial infarction. Early restoration of blood flow in occluded coronary artery is the mainstay of therapy and it can be achieved by either thrombolytic therapy or primary percutaneous coronary intervention (P-PCI) or a combination of these two in many different ways. It has been proved that primary PCI is better than thrombolytic therapy in establishing early and effective recanalization of infarct related artery, reducing major adverse cardiovascular events (MACE) and increasing survival. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2018.11.021DOI Listing
December 2018
2 Reads

Safety and efficacy of stentablation with rotational atherectomy for the management of underexpanded and undilatable coronary stents.

Cardiovasc Revasc Med 2019 Jan 15. Epub 2019 Jan 15.

Division of Cardiology, Medical College of Georgia at Augusta University, Augusta, GA, USA.

Introduction: Coronary stent underexpansion is associated with in-stent restenosis and few interventions are available for the management of undilatable underexpanded stents. Stentablation (SA) with rotational atherectomy (RA) is a unique application and has previously been described with encouraging results. Data regarding SA is limited to case reports and small case series; therefore, reasonable concern persists regarding procedural safety and long-term outcomes. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2019.01.013DOI Listing
January 2019
1 Read

The relation between optical coherence tomography-detected layered pattern and acute side branch occlusion after provisional stenting of coronary bifurcation lesions.

Cardiovasc Revasc Med 2018 Dec 28. Epub 2018 Dec 28.

Clinical Trials Center, Cardiovascular Research Foundation, New York, NY, USA; NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, NY, USA. Electronic address:

Background/purpose: Layered pattern (presumed to be healed plaque after a thrombotic event) can be observed by optical coherence tomography (OCT). We sought to assess the ability of OCT-detected plaque composition to predict acute side branch (SB) occlusion after provisional bifurcation stenting.

Methods: This is a retrospective observational study using pre-intervention OCT in the main vessel to predict Thrombolysis in Myocardial Infarction (TIMI) flow grade ≤1 in a SB (diameter ≥ 1. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2018.12.021DOI Listing
December 2018

Outcomes of trans-radial PCI compared to trans-femoral PCI in veterans with anemia: Insight from the VA Clinical Assessment, Reporting and Tracking (CART) program.

Cardiovasc Revasc Med 2019 Jan 14. Epub 2019 Jan 14.

University of Colorado-School of Medicine, Aurora, CO, United States of America; VA Rocky Mountain Regional Medical Center, Aurora, CO, United States of America.

Background: Pre-procedural anemia is associated with increased bleeding and mortality post-percutaneous coronary intervention (PCI). The effect of trans-radial PCI (TR-PCI) in improving outcomes compared to trans-femoral PCI (TF-PCI) in anemic patients is not known.

Objective: The aim of this study was to evaluate the association between arterial access site (radial versus femoral) and outcomes in anemic Veterans undergoing PCI. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2019.01.014DOI Listing
January 2019

Orbiting a treatment for some with critical hand ischemia.

Authors:
Ian C Gilchrist

Cardiovasc Revasc Med 2019 Jan 10. Epub 2019 Jan 10.

Pennsylvania State University, College of Medicine, Heart & Vascular Institute, Hershey, PA, United States of America. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2019.01.007DOI Listing
January 2019
1 Read

Transcatheter closure of left ventricular apical pseudoaneurysm with an amplatzer vascular plug.

Cardiovasc Revasc Med 2019 Jan 6. Epub 2019 Jan 6.

Cardiovascular Department, Cardiomyopathy Center, Azienda Sanitaria Universitaria Integrata di Trieste, Trieste, Italy; Postgraduate School in Cardiovascular Diseases, University of Trieste, Italy.

We report the case of a 66-year-old man, with a history of previous chest radiation therapy admitted to ED for heart failure. The patient was diagnosed with severe aortic stenosis and multivessel coronary disease and underwent surgical aortic valve replacement and coronary artery by pass grafts. Cardiac surgery was complicated by a left ventricular perforation by a venting catheter. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15538389193003
Publisher Site
http://dx.doi.org/10.1016/j.carrev.2019.01.002DOI Listing
January 2019
5 Reads

Direct comparison of optical coherence tomography and high-definition 60-MHz intravascular ultrasound imaging of intra-procedural stent thrombosis in a patient with acute coronary syndrome.

Cardiovasc Revasc Med 2018 Dec 7. Epub 2018 Dec 7.

Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

An 80-year-old man with ST-segment elevation myocardial infraction underwent coronary stenting using an everolimus-eluting stent, which resulted in a good coronary flow with no residual stenosis. However, 10 min after final coronary angiography, the patient complained of chest discomfort and the ECG again showed ST elevation. Repeat coronary angiography revealed multiple contrast filling defects in the stent. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15538389183045
Publisher Site
http://dx.doi.org/10.1016/j.carrev.2018.10.011DOI Listing
December 2018
4 Reads

Safe Exchange of a Transfemoral Impella Pump.

Cardiovasc Revasc Med 2018 Dec 19. Epub 2018 Dec 19.

Cardiac Arrest Center, Advanced Heart Failure Unit, Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.

Mechanical circulatory support with the Impella pump is established in many centers treating patients with cardiogenic shock. While Impella pumps usually run very stable, it may still be possible that one needs to remove the pump for using the same vascular access for different reasons. Unfortunately, until now it had been nearly impossible to remove the pump while preserving arterial access without severe bleeding. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2018.12.006DOI Listing
December 2018
3 Reads

In complex coronary bifurcations, should a dedicated stent be better than a dedicated approach?

Cardiovasc Revasc Med 2019 Jan 6. Epub 2019 Jan 6.

Institute of Cardiology and Center of Excellence on Aging, "G. d'Annunzio" University - Chieti, Italy; Interventional Cardiology Unit, SS. Annunziata Hospital, Chieti, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2019.01.003DOI Listing
January 2019
1 Read

Sirolimus nanoparticles: (Delivering) a new hope in stentless percutaneous coronary intervention?

Cardiovasc Revasc Med 2019 Jan 6. Epub 2019 Jan 6.

Department of Cardiology, National University Heart Centre, Singapore, Singapore.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2019.01.004DOI Listing
January 2019
1 Read

The feasibility and safety of ambulatory percutaneous coronary interventions in complex lesions.

Cardiovasc Revasc Med 2018 Dec 8. Epub 2018 Dec 8.

Complejo Hospitalario Universitario de Albacete, Albacete, Spain.

Background: The safety and feasibility of ambulatory PCI has been demonstrated in selected patients with "simple" lesions, but it is not well known whether it could be applied in more "complex" scenarios.

Methods: Main objective is to assess the feasibility and safety of ambulatory complex PCI. Prospective multicentre registry of 1047 consecutive patients planned for ambulatory trans-radial PCI. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15538389183057
Publisher Site
http://dx.doi.org/10.1016/j.carrev.2018.12.001DOI Listing
December 2018
5 Reads

Culprit vessel only versus multivessel percutaneous coronary intervention in acute myocardial infarction with cardiogenic shock: A systematic review and meta-analysis.

Cardiovasc Revasc Med 2018 Dec 21. Epub 2018 Dec 21.

Division of Cardiovascular Medicine, East Tennessee State University, Johnson City, TN, USA. Electronic address:

Background: Previous studies comparing outcomes between culprit vessel only percutaneous coronary intervention (CV-PCI) versus multivessel percutaneous coronary intervention (MV-PCI) in patients with cardiogenic shock in the setting of acute myocardial infarction have shown conflicting results. This meta-analysis investigates the optimal approach for management of these patients considering recently published data.

Methods: Electronic databases including MEDLINE, ClinicalTrials. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15538389183061
Publisher Site
http://dx.doi.org/10.1016/j.carrev.2018.12.015DOI Listing
December 2018
6 Reads

Transcatheter versus surgical aortic valve replacement in low-risk surgical patients: A meta-analysis of randomized clinical trials.

Cardiovasc Revasc Med 2019 Jan 4. Epub 2019 Jan 4.

Brigham and Women's Hospital Heart & Vascular Center, Harvard Medical School, Boston, MA, USA. Electronic address:

Background: Transcatheter aortic valve replacement (TAVR) is a valid option for patients with high or intermediate surgical risk. However, clinical outcomes of TAVR in low-risk patients are lacking. Our aim was to evaluate the efficacy and safety of TAVR versus surgical aortic valve replacement (SAVR) in low-surgical-risk patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2018.12.023DOI Listing
January 2019
2 Reads

Effect of plaque composition, morphology, and burden on DESolve novolimus-eluting bioresorbable vascular scaffold expansion and eccentricity - An optical coherence tomography analysis.

Cardiovasc Revasc Med 2018 Aug 2. Epub 2018 Aug 2.

University of Giessen, Department of Cardiology, Giessen, Germany. Electronic address:

Objective: This study of patients treated with novolimus-eluting bioresorbable scaffold (BRS) investigated the impact of plaque burden on the acute mechanical performance of the BRS and the short-term outcome.

Methods: A total of 15 patients were enrolled. The following parameters were derived from optical coherence tomography (OCT) during the final pullback: mean and minimum area, residual area stenosis, incomplete strut apposition, tissue prolapse, scaffold expansion index (SEI), scaffold eccentricity index (SEC), symmetry index, strut fracture, and edge dissection. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2018.07.030DOI Listing
August 2018
1 Read

Health economic evaluation of an ultrathin, bioresorbable polymer sirolimus-eluting coronary stent compared to a thin, durable polymer everolimus-eluting stent.

Cardiovasc Revasc Med 2018 Nov 20. Epub 2018 Nov 20.

BIOTRONIK, Buelach, Switzerland.

Objectives: The study estimated the health economic impact of a latest generation coronary stent with ultrathin struts and bioresorbable polymer coating.

Background: The recent BIOFLOW V trial, an international FDA approval trial (ClinicalTrials.gov: NCT02389946), has shown that an ultrathin, bioresorbable polymer sirolimus-eluting stent had a significantly lower rate of target lesion failure and target vessel-related myocardial infarction than a thin, durable polymer everolimus-eluting stent at 12 months, driven by a lower rate of peri-procedural myocardial infarction (ppMI). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2018.11.006DOI Listing
November 2018
5 Reads

Acute, in-hospital outcome of percutaneous coronary intervention for in-stent chronic total occlusion.

Cardiovasc Revasc Med 2018 Dec 19. Epub 2018 Dec 19.

Department of Cardiology, Helios Clinic Velbert, Velbert, Germany.

Background: Percutaneous coronary intervention (PCI) of total chronic total occlusion (CTO) still remains a major challenge in interventional cardiology. Recanalization of in-stent CTO (IS-CTO) is associated with inferior success rates. This present study aims to comparatively evaluate the acute outcome of patients with IS-CTO and de novo CTO. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2018.12.007DOI Listing
December 2018
2 Reads

HDL-C is a marker of coronary artery disease severity and inflammation in patients on statin therapy.

Cardiovasc Revasc Med 2018 Dec 27. Epub 2018 Dec 27.

Inova Center for Thrombosis Research and Drug Development, Inova Heart and Vascular Institute, Falls Church FVA, USA. Electronic address:

Introduction: Low high-density lipoprotein (HDL-C) and inflammation are risk factors for coronary artery disease (CAD). However, limited data are available determining the role of HDL-C sub-particles HDL-C and HDL-C for assessing CAD severity in patients on statin therapy.

Methods: Blood samples were obtained prior to cardiac catheterization in 304 consecutive patients with suspected CAD on statin therapy in this sub-analysis of Multi-Analyte, thrombogenic, and Genetic Markers of Atherosclerosis (MAGMA, NCT01276678) study. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2018.12.019DOI Listing
December 2018
1 Read

Resorbable magnesium scaffold in coronary bifurcations - Report of in vitro experiments.

Cardiovasc Revasc Med 2018 Dec 5. Epub 2018 Dec 5.

The Lambe Institute for Translational Medicine and Curam, National University of Ireland, Galway, Ireland. Electronic address:

Objectives: The aim of this work is to evaluate in an in vitro setting the behavior of resorbable magnesium scaffolds (RMS) in bifurcations.

Background: As coronary bifurcations represent an important portion of all PCIs, it is crucial to understand whether RMS is applicable in these complex lesions.

Methods: Performance of RMS was evaluated with focus on bifurcations. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2018.11.023DOI Listing
December 2018
2 Reads

Disparate impact of ischemic injury on regional wall dysfunction in acute anterior vs inferior myocardial infarction.

Cardiovasc Revasc Med 2018 Dec 21. Epub 2018 Dec 21.

Department of Cardiovascular Medicine, Beaumont Hospital Royal Oak, MI, USA.

Background: Acute transmural ischemia should induce similar magnitude of wall motion abnormality (WMA) in both anterior myocardial infarction (AMI) and inferior (IMI). However, patients with AMI generally suffer more severe hemodynamic compromise.

Methods: This retrospective study compared WMA's in ST segment elevation MI patients undergoing primary reperfusion and subsequent cardiac MRI. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2018.12.016DOI Listing
December 2018
2 Reads

Trends and outcomes of optical coherence tomography use: 877 patients single-center experience.

Cardiovasc Revasc Med 2018 Dec 21. Epub 2018 Dec 21.

Institute of Cardiology, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.

Background: Optical-coherence-tomography (OCT) is an emerging invasive coronary imaging with still undefined clinical value. Recent data have underlined daily impact of such technique in several clinical settings such as acute coronary syndromes (ACS) and percutaneous coronary intervention (PCI) guidance. We aimed at assessing the trends and outcomes of OCT use in a high-volume percutaneous coronary interventions (PCI)-center. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2018.12.017DOI Listing
December 2018
1 Read

Percutaneous closure of persistent atrial septal defects after pulmonary vein isolation.

Cardiovasc Revasc Med 2018 Nov 22. Epub 2018 Nov 22.

Department of Cardiology, Geisinger Medical Center, 100 North Academy Drive, Danville, PA, United States of America.

Pulmonary vein isolation (PVI) with radiofrequency or cryoballoon ablation to treat atrial fibrillation requires trans-septal puncture. This creates a small iatrogenic atrial septal defect (iASD). In most patients, the defect spontaneously closes after 3-6 months. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2018.10.020DOI Listing
November 2018
2 Reads

Takotsubo syndrome: State-of-the-art review by an expert panel - Part 2.

Cardiovasc Revasc Med 2018 Nov 17. Epub 2018 Nov 17.

Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, United States of America. Electronic address:

In part 2 of this two-part manuscript on takotsubo syndrome (TTS), we discuss typical biomarkers (particularly excess catecholamines and what kinds of electrocardiographic information operators should look for) and numerous complications the syndrome can cause. This consensus paper is the result of a multinational effort aiming to summarize the current state of the art on TTS. Several novel and unique sections are emphasized in this document, including the current state of the art on genetics of takotsubo syndrome, microRNAs (miRs), racial differences, role of cardiac spectroscopy and intracoronary imaging, as well as mechanical circulatory support. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15538389183053
Publisher Site
http://dx.doi.org/10.1016/j.carrev.2018.11.016DOI Listing
November 2018
9 Reads

Racial variation in the complexity of coronary artery disease in patients with acute ST-segment elevation myocardial infarction.

Cardiovasc Revasc Med 2018 Dec 16. Epub 2018 Dec 16.

Sands-Constellation Heart Institute, Rochester General Hospital, Rochester, NY, United States of America.

Background: Racial variations in presentation of patients with ST-segment elevation myocardial infarction (STEMI) have been suggested.

Methods: This was a retrospective analysis of a tertiary center from 2012 to 2016. We included patients presenting with acute STEMI who received primary percutaneous coronary intervention (PCI). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2018.12.012DOI Listing
December 2018
1 Read

Potent stent-less procedure using rotational atherectomy and drug-coated balloon to right coronary ostial lesion.

Cardiovasc Revasc Med 2018 Dec 11. Epub 2018 Dec 11.

Department of Cardiology, Kyoto First Red Cross Hospital, Honmachi, Higashiyama-ku, Kyoto 605-0981, Japan.

Background: Even in the drug-eluting stent era, ostial lesion of the right coronary artery (RCA) still remains therapeutic challenge for interventional cardiologists. Case Series Case 1 (76 y.o. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2018.11.019DOI Listing
December 2018
2 Reads

Intravenous antiplatelet therapy bridging in patients undergoing cardiac or non-cardiac surgery following percutaneous coronary intervention.

Cardiovasc Revasc Med 2018 Nov 22. Epub 2018 Nov 22.

University of Texas Southwestern Medical Center, Dallas, TX, United States of America; Veterans Affairs North Texas System Dallas Texas, Dallas, TX, United States of America. Electronic address:

Background: The effect of perioperative bridging therapy on risks of ischemic cardiac events and major bleeding complications in patients on dual antiplatelet therapy (DAPT) following percutaneous coronary intervention (PCI) remains undefined.

Methods: We report on 60 consecutive patients between 2010 and 2017 who required cardiac (CS; n = 15) or non-cardiac (NCS; n = 45) surgeries following PCI at our institution. Short-acting intravenous (IV) antiplatelet (APT) bridging with eptifibatide, tirofiban and cangrelor were instituted after DAPT interruption. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15538389183053
Publisher Site
http://dx.doi.org/10.1016/j.carrev.2018.11.018DOI Listing
November 2018
9 Reads

Clinical impact of diabetes mellitus on short-term outcomes and in-hospital mortality of cardiac mechanical support with left ventricular assist device (LVAD): A retrospective study from a national database.

Cardiovasc Revasc Med 2018 Dec 14. Epub 2018 Dec 14.

Division of Cardiology, Department of Internal Medicine, Detroit Medical Center/Wayne State University School of Medicine, Detroit, MI, USA.

Background: Cardiac support with left ventricular assist devices (LVAD) is a growing field. LVAD are increasingly used for patients with advanced congestive heart failure. Multiple studies have evaluated the outcomes of cardiac support with LVAD in patients with and without diabetes mellitus (DM), yet we still have conflicting results. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15538389183061
Publisher Site
http://dx.doi.org/10.1016/j.carrev.2018.12.011DOI Listing
December 2018
11 Reads

Trans-catheter aortic valve replacement and surgical aortic valve replacement outcomes in patients with dialysis: Systematic review and meta-analysis.

Cardiovasc Revasc Med 2018 Dec 10. Epub 2018 Dec 10.

Internal Medicine, University of Kansas School of Medicine - Wichita, 1010 N Kansas, Wichita, 67214 KS, USA; Cardiology, Heartland Cardiology/Wesley Medical Center, 550 N Hillside, Wichita, 67214 KS, USA.

Background: Dialysis is associated with higher rate of aortic valve calcification and higher cardiovascular mortality. Transcatheter aortic valve replacement (TAVR) is an established alternative for surgical aortic valve replacement (SAVR) in patients with higher and intermediate co-morbidities including dialysis.

Methods: Two independent investigators systematically searched Medline, Cochrane, and Web of Science. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15538389183057
Publisher Site
http://dx.doi.org/10.1016/j.carrev.2018.12.002DOI Listing
December 2018
6 Reads

Biodegradable-polymer versus polymer-free drug eluting stents for the treatment of coronary artery disease.

Cardiovasc Revasc Med 2018 Dec 14. Epub 2018 Dec 14.

Monash Cardiovascular Research Centre, Monash University and MonashHeart, Monash Health, Melbourne, Victoria, Australia. Electronic address:

Background/purpose: Biodegradable-polymer (BP) and polymer-free (PF) drug eluting stents (DES) were developed to reduce the risk of delayed arterial healing observed with durable-polymer (DP) platforms. Although trials demonstrate BP-DES and PF-DES are non-inferior to DP-DES, there is limited data directly comparing these technologies. We performed a meta-analysis to assess the efficacy and safety of BP-DES versus PF-DES for the treatment of coronary artery disease. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15538389183061
Publisher Site
http://dx.doi.org/10.1016/j.carrev.2018.12.010DOI Listing
December 2018
2 Reads

Acute and 30-day safety and effectiveness evaluation of Eximo Medical's B-Laser™, a novel atherectomy device, in subjects affected with infrainguinal peripheral arterial disease: Results of the EX-PAD-03 trial.

Cardiovasc Revasc Med 2018 Nov 29. Epub 2018 Nov 29.

Holy Name Medical Center, Teaneck, USA.

Background: B-Laser™ is a novel atherectomy device that uses a solid-state third harmonic pulsed Nd:YAG laser with an output of 355 nm. Early data showed that the B-Laser™ is safe in treating a broad range of infrainguinal arterial lesions. We present the results of the EX-PAD-03 U. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2018.11.022DOI Listing
November 2018
7 Reads

Severe coronary artery spasm presenting as Prinzmetal's angina following cardiac transplantation.

Cardiovasc Revasc Med 2018 Dec 22;19(8S):13-15. Epub 2018 Jun 22.

Columbia University Medical Center/New York-Presbyterian Hospital and the Cardiovascular Research Foundation, New York, NY, United States of America. Electronic address:

We report the case of a 63-year-old woman who presented with typical angina (crushing chest pain) and recurrent frank syncope two years after her heart transplant. She was observed to have transient ST-elevations on continuous ST-segment monitoring that correlated with her symptoms, and coronary angiography revealed severe and transient spasm of the right coronary artery concurrent with her symptoms and ST-segment changes. The observed spasm completely resolved following administration of intracoronary nitroglycerin in the cardiac cathetherization laboratory. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.carrev.2018.06.019DOI Listing
December 2018
1 Read